Jen advises technology and life sciences clients on capital markets and general public company corporate matters. Jen represents companies and underwriters in a wide range of capital markets transactions, including initial public offerings, direct listings and follow-on offerings in equity and debt. She also represents public companies in securities law compliance and disclosure matters and corporate governance matters.
*Representing the representatives on behalf of the underwriters/initial purchasers, including such investment banks as Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities, RBC Capital Markets, Allen & Company, Pacific Crest Securities, a division of KeyBanc Capital Markets, Piper Jaffray, and UBS Securities, among others.
*Representing the representatives on behalf of the underwriters/initial purchasers, including such investment banks as Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities, RBC Capital Markets, Allen & Company, Pacific Crest Securities, a division of KeyBanc Capital Markets, Piper Jaffray, and UBS Securities, among others.
Recognition Recognition Recognition
Recognition Recognition Recognition
2022
Named Jen a Law360 Rising Star for Capital Markets.